These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 604189)

  • 1. Serum, cerebrospinal fluid, and brain levels of bile acids in patients with fulminant hepatic failure.
    Bron B; Waldram R; Silk DB; Williams R
    Gut; 1977 Sep; 18(9):692-6. PubMed ID: 604189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of bile secretion in the rat by serum ultrafiltrates and fractions from patients with fulminant hepatic failure.
    Fukumoto Y; Hughes RD; Gove CD; Williams R
    Br J Exp Pathol; 1988 Jun; 69(3):403-11. PubMed ID: 3390389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of rat brain Na+,K+-ATPase activity by serum from patients with fulminant hepatic failure.
    Seda HW; Hughes RD; Gove CD; Williams R
    Hepatology; 1984; 4(1):74-9. PubMed ID: 6319261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Middle molecules in the serum, brain, liver and urine of galactosamine-induced fulminant hepatic failure rats.
    Shu CD; Chang TM
    Int J Artif Organs; 1983 Sep; 6(5):273-7. PubMed ID: 6642726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bile acids in patients with liver failure supported with a bioartificial liver.
    Pazzi P; Morsiani E; Vilei MT; Granato A; Rozga J; Demetriou AA; Muraca M
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1547-54. PubMed ID: 12182755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome.
    Acharya SK; Dasarathy S; Kumer TL; Sushma S; Prasanna KS; Tandon A; Sreenivas V; Nijhawan S; Panda SK; Nanda SK; Irshad M; Joshi YK; Duttagupta S; Tandon RK; Tandon BN
    Hepatology; 1996 Jun; 23(6):1448-55. PubMed ID: 8675163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure.
    Hiraoka A; Horiike N; Akbar SM; Michitaka K; Matsuyama T; Onji M
    J Gastroenterol; 2005 Jan; 40(1):52-6. PubMed ID: 15692789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspects of bile acid metabolism in liver diseases(author's transl)].
    Horak W
    Acta Med Austriaca Suppl; 1975; 4():1-38. PubMed ID: 1064281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.
    Weiss N; Rosselli M; Mouri S; Galanaud D; Puybasset L; Agarwal B; Thabut D; Jalan R
    Metab Brain Dis; 2017 Apr; 32(2):369-376. PubMed ID: 27730496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free oxysterols and bile acids including conjugates - Simultaneous quantification in human plasma and cerebrospinal fluid by liquid chromatography-tandem mass spectrometry.
    Reinicke M; Schröter J; Müller-Klieser D; Helmschrodt C; Ceglarek U
    Anal Chim Acta; 2018 Dec; 1037():245-255. PubMed ID: 30292299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids in liver disease associated with inflammatory bowel disease.
    Siegel JH; Barnes S; Morris JS
    Digestion; 1977; 15(6):469-81. PubMed ID: 913913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased turnover of Gc-globulin in patients with hepatic encephalopathy.
    Schiødt FV; Clemmesen JO; Bondesen S; Dahl B; Ott P
    Scand J Gastroenterol; 2001 Sep; 36(9):998-1003. PubMed ID: 11521994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulminant hepatic failure: summary of a workshop.
    Hoofnagle JH; Carithers RL; Shapiro C; Ascher N
    Hepatology; 1995 Jan; 21(1):240-52. PubMed ID: 7806160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and urinary zinc in fulminant hepatic failure.
    Nandi SS; Chawla YK; Nath R; Dilawari JB
    J Gastroenterol Hepatol; 1989; 4(3):209-13. PubMed ID: 2518804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood and brain concentrations of mercaptans in hepatic and methanethiol induced coma.
    Al Mardini H; Bartlett K; Record CO
    Gut; 1984 Mar; 25(3):284-90. PubMed ID: 6698445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional cerebral blood flow and CO2 reactivity in fulminant hepatic failure.
    Durham S; Yonas H; Aggarwal S; Darby J; Kramer D
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):329-35. PubMed ID: 7860666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-100b and neuron-specific enolase in patients with fulminant hepatic failure.
    Strauss GI; Christiansen M; Møller K; Clemmesen JO; Larsen FS; Knudsen GM
    Liver Transpl; 2001 Nov; 7(11):964-70. PubMed ID: 11699032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid drainage and cranial decompression prolong survival in rats with fulminant hepatic failure.
    Yamamoto S; Steers JL; Wharen RE; Eckman CB; Nguyen JH
    Transpl Int; 2006 Aug; 19(8):675-82. PubMed ID: 16827685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum octopamine, coma, and charcoal haemoperfusion in fulminant hepatic failure.
    Chase RA; Trewby PN; Davis M; Williams R
    Eur J Clin Invest; 1977 Oct; 7(5):351-4. PubMed ID: 411665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.